Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric S Kilpatrick

Showing results (41-50 of 124) with videos related to

Pageof 13
Sort By:
Diabetes Care|March 1, 2007
Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: "double diabetes" in the Diabetes Control and Complications TrialEric S Kilpatrick, Alan S Rigby, Stephen L Atkin
Diabetes Care|November 27, 2009
International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes: response to the International Expert CommitteeEric S Kilpatrick, Zachary T Bloomgarden, Paul Z Zimmet
Annals of Clinical Biochemistry|January 25, 2019
A survey of clinical laboratory instrument verification in the UK and New ZealandMatthew Hand, Andrea Crampton, Annette Thomas, et al.
Diabetes Care|July 25, 2008
A1C variability and the risk of microvascular complications in type 1 diabetes: data from the Diabetes Control and Complications TrialEric S Kilpatrick, Alan S Rigby, Stephen L Atkin
Diabetes Care|June 25, 2009
Effect of glucose variability on the long-term risk of microvascular complications in type 1 diabetesEric S Kilpatrick, Alan S Rigby, Stephen L Atkin
Diabetes & Metabolic Syndrome|April 14, 2024
Using nephropathy as an outcome to determine the HbA1c diagnostic threshold for type 2 diabetesAlexandra E Butler, Steven C Hunt, Eric S Kilpatrick
Annals of Clinical Biochemistry|December 5, 2024
The variability of measured and calculated low-density lipoprotein (LDL) cholesterol in statin-treated diabetes patientsEric S Kilpatrick, Anders Kallner, Stephen L Atkin, et al.
Frontiers in Endocrinology|May 31, 2019
The Effects of Soy Protein and Cocoa With or Without Isoflavones on Glycemic Control in Type 2 Diabetes. A Double-Blind, Randomized, Placebo-Controlled StudyJudit Konya, Thozhukat Sathyapalan, Eric S Kilpatrick, et al.
Clinical Chemistry and Laboratory Medicine|June 17, 2006
Use of haemolysis index to estimate potassium concentration in in-vitro haemolysed serum samplesJohn Shepherd, Maria H Warner, Philip Poon, et al.
Annals of Clinical Biochemistry|October 10, 2024
Familial hypercholesterolaemia with high triglycerides: A diagnostic challengeSuha Ahmed, Marwa Elgizouli, Eric S Kilpatrick, et al.
Pageof 13

Showing results (41-50 of 124) with videos related to

Sort By:
Pageof 13
Diabetes Care|March 1, 2007
Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: "double diabetes" in the Diabetes Control and Complications TrialEric S Kilpatrick, Alan S Rigby, Stephen L Atkin
Diabetes Care|November 27, 2009
International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes: response to the International Expert CommitteeEric S Kilpatrick, Zachary T Bloomgarden, Paul Z Zimmet
Annals of Clinical Biochemistry|January 25, 2019
A survey of clinical laboratory instrument verification in the UK and New ZealandMatthew Hand, Andrea Crampton, Annette Thomas, et al.
Diabetes Care|July 25, 2008
A1C variability and the risk of microvascular complications in type 1 diabetes: data from the Diabetes Control and Complications TrialEric S Kilpatrick, Alan S Rigby, Stephen L Atkin
Diabetes Care|June 25, 2009
Effect of glucose variability on the long-term risk of microvascular complications in type 1 diabetesEric S Kilpatrick, Alan S Rigby, Stephen L Atkin
Diabetes & Metabolic Syndrome|April 14, 2024
Using nephropathy as an outcome to determine the HbA1c diagnostic threshold for type 2 diabetesAlexandra E Butler, Steven C Hunt, Eric S Kilpatrick
Annals of Clinical Biochemistry|December 5, 2024
The variability of measured and calculated low-density lipoprotein (LDL) cholesterol in statin-treated diabetes patientsEric S Kilpatrick, Anders Kallner, Stephen L Atkin, et al.
Frontiers in Endocrinology|May 31, 2019
The Effects of Soy Protein and Cocoa With or Without Isoflavones on Glycemic Control in Type 2 Diabetes. A Double-Blind, Randomized, Placebo-Controlled StudyJudit Konya, Thozhukat Sathyapalan, Eric S Kilpatrick, et al.
Clinical Chemistry and Laboratory Medicine|June 17, 2006
Use of haemolysis index to estimate potassium concentration in in-vitro haemolysed serum samplesJohn Shepherd, Maria H Warner, Philip Poon, et al.
Annals of Clinical Biochemistry|October 10, 2024
Familial hypercholesterolaemia with high triglycerides: A diagnostic challengeSuha Ahmed, Marwa Elgizouli, Eric S Kilpatrick, et al.
Pageof 13